Watchlist Price Alert

Hims & Hers Health Inc. (HIMS)

NYSE: HIMS · Real-Time Price · USD

41.86

1.04 (2.55%)

At close: May 05, 2025, 3:59 PM

40.60

-3.01%

After-hours: May 05, 2025, 06:26 PM EDT

2.55% (1D)

Bid	40.47
Market Cap	9.01B
Revenue (ttm)	1.48B
Net Income (ttm)	126.04M
EPS (ttm)	0.53
PE Ratio (ttm)	78.98
Forward PE	42.23
Analyst	Hold

Ask	40.6
Volume	61,868,638
Avg. Volume (20D)	29,874,890
Open	42.28
Previous Close	40.82
Day's Range	39.84 - 43.10
52-Week Range	11.45 - 72.98
Beta	1.66

About HIMS

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmeti...

[Read more]

Industry Household & Personal Products

Sector Consumer Defensive

IPO Date Sep 13, 2019

Employees 1,637

Stock Exchange NYSE

Ticker Symbol HIMS

Website https://www.forhims.com

Full Company Profile

Analyst Forecast

According to 12 analyst ratings, the average rating for HIMS stock is "Hold." The 12-month stock price forecast is $31.5, which is a decrease of -24.75% from the latest price.

Stock Forecasts

Earnings Surprise

New

Hims & Hers Health has released their quartely earnings on May 5, 2025:

Revenue of $586.01M exceeds estimates by $47.14M, with 110.67% YoY growth.

EPS of 0.2 exceeds estimates by 0.08, with 300.00% YoY growth.

Next Earnings Release

Hims & Hers Health Inc. is scheduled to release its earnings on May 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

12 minutes ago New

Hims & Hers Health shares are trading lower after ... Unlock content with Pro Subscription

1 week ago

+23.03%

Hims & Hers Health shares are trading higher after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.

News

1 day ago · 247wallst.com

Hims & Hers (HIMS) Blows Out Earnings Expectations

Hims & Hers Health, Inc. reported a strong financial performance for Q1 2025, with revenue reaching $586 million, marking a 111% increase year-over-year.

1 day ago · cnbc.com

Hims & Hers gives weak outlook but says more collaborations are coming

Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft guidance. For its second quarter, Hims & Hers said it expected to report reven...

1 day ago · wsj.com

Hims & Hers Health Revenue Jumps, But Outlook Disappoints

Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook missed Wall Street's expectations.

1 day ago · youtube.com

EARNINGS ALERT: HIMS

While Palantir (PLTR) trading was vastly unchanged after hours , Hims & Hers (HIMS) saw some downside action following its earnings. George Tsilis notes it has "become quite profitable over the years,...

1 day ago · businesswire.com

Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter...

1 day ago · youtube.com

HIMS Earnings Ahead: Wegovy Offers Upside, Analysts Advise Caution

"There's a sense of caution" heading into Hims & Hers (HIMS) earnings, says Caroline Woods. The telehealth company is up over 65% so far in 2025 but has fallen more than 40% off its February highs.

1 day ago · cnbc.com

Hims & Hers brings former Amazon executive into C-suite

Hims & Hers Health announced Nader Kabbani will join the telehealth company as its new chief operations officer. Kabbani spent nearly 20 years at Amazon, where he oversaw the launch of Amazon Pharmacy...

1 day ago · businesswire.com

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A season...

4 days ago · zacks.com

Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings?

The continued solid uptake of Hims & Hers offerings and expanding subscriber base are likely to have driven the company's performance in the first quarter of 2025.

5 days ago · seekingalpha.com

Hims & Hers: Revolutionizing Healthcare

The company's vertically integrated platform enhances scalability and efficiency, controlling the entire patient experience from consultation to medication delivery. Partnerships, especially with Novo...

Load More News